These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26842712)

  • 1. Nucleobindin 2 (NUCB2) in human endometrial carcinoma: a potent prognostic factor associated with cell proliferation and migration.
    Takagi K; Miki Y; Tanaka S; Hashimoto C; Watanabe M; Sasano H; Ito K; Suzuki T
    Endocr J; 2016; 63(3):287-99. PubMed ID: 26842712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleobindin 2 in human breast carcinoma as a potent prognostic factor.
    Suzuki S; Takagi K; Miki Y; Onodera Y; Akahira J; Ebata A; Ishida T; Watanabe M; Sasano H; Suzuki T
    Cancer Sci; 2012 Jan; 103(1):136-43. PubMed ID: 21988594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients.
    Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Wang Z; Xie H; Dai B; Xu J; Ye D
    Oncotarget; 2017 May; 8(21):35244-35254. PubMed ID: 27806328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleobindin-2/nesfatin-1 enhances the cell proliferation, migration, invasion and epithelial-mesenchymal transition in gastric carcinoma.
    Ren L; Bao D; Wang L; Xu Q; Xu Y; Shi Z
    J Cell Mol Med; 2022 Oct; 26(19):4986-4994. PubMed ID: 36065769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
    Qi C; Ma H; Zhang HT; Gao JD; Xu Y
    Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nesfatin-1/Nucleobindin-2 Is a Potent Prognostic Marker and Enhances Cell Proliferation, Migration, and Invasion in Bladder Cancer.
    Liu GM; Xu ZQ; Ma HS
    Dis Markers; 2018; 2018():4272064. PubMed ID: 30327690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution and neuropeptide coexistence of nucleobindin-2 mRNA/nesfatin-like immunoreactivity in the rat CNS.
    Foo KS; Brismar H; Broberger C
    Neuroscience; 2008 Oct; 156(3):563-79. PubMed ID: 18761059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ontogenic pattern of nucleobindin-2/nesfatin-1 expression in the gastroenteropancreatic tissues and serum of Sprague Dawley rats.
    Mohan H; Unniappan S
    Regul Pept; 2012 Apr; 175(1-3):61-9. PubMed ID: 22387700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrients differentially regulate nucleobindin-2/nesfatin-1 in vitro in cultured stomach ghrelinoma (MGN3-1) cells and in vivo in male mice.
    Mohan H; Ramesh N; Mortazavi S; Le A; Iwakura H; Unniappan S
    PLoS One; 2014; 9(12):e115102. PubMed ID: 25506938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutrient status modulates the expression of nesfatin-1 encoding nucleobindin 2A and 2B mRNAs in zebrafish gut, liver and brain.
    Hatef A; Shajan S; Unniappan S
    Gen Comp Endocrinol; 2015 May; 215():51-60. PubMed ID: 25260251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade.
    Urabe R; Hachisuga T; Kurita T; Kagami S; Kawagoe T; Matsuura Y; Shimajiri S
    J Obstet Gynaecol Res; 2014 Mar; 40(3):812-9. PubMed ID: 24246002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraventricular NUCB2/nesfatin-1 rises in synchrony with feeding suppression during early light phase in rats.
    Sedbazar U; Maejima Y; Nakata M; Mori M; Yada T
    Biochem Biophys Res Commun; 2013 May; 434(3):434-8. PubMed ID: 23583201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose, amino acids and fatty acids directly regulate ghrelin and NUCB2/nesfatin-1 in the intestine and hepatopancreas of goldfish (Carassius auratus) in vitro.
    Bertucci JI; Blanco AM; Canosa LF; Unniappan S
    Comp Biochem Physiol A Mol Integr Physiol; 2017 Apr; 206():24-35. PubMed ID: 28089858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysis.
    Li SS; Xue WC; Khoo US; Ngan HY; Chan KY; Tam IY; Chiu PM; Ip PP; Tam KF; Cheung AN
    Histopathology; 2005 Mar; 46(3):307-13. PubMed ID: 15720416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 14-3-3sigma in endometrial cancer--a possible prognostic marker in early-stage cancer.
    Ito K; Suzuki T; Akahira J; Sakuma M; Saitou S; Okamoto S; Niikura H; Okamura K; Yaegashi N; Sasano H; Inoue S
    Clin Cancer Res; 2005 Oct; 11(20):7384-91. PubMed ID: 16243811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancer.
    Guo L; Chen S; Jiang H; Huang J; Jin W; Yao S
    Int J Clin Exp Pathol; 2014; 7(5):2102-12. PubMed ID: 24966918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nesfatin-1 inhibits ovarian epithelial carcinoma cell proliferation in vitro.
    Xu Y; Pang X; Dong M; Wen F; Zhang Y
    Biochem Biophys Res Commun; 2013 Nov; 440(4):467-72. PubMed ID: 23764403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraventricular NUCB2/nesfatin-1 is directly targeted by leptin and mediates its anorexigenic effect.
    Darambazar G; Nakata M; Okada T; Wang L; Li E; Shinozaki A; Motoshima M; Mori M; Yada T
    Biochem Biophys Res Commun; 2015 Jan; 456(4):913-8. PubMed ID: 25534851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of pS2 protein in endometrial carcinomas: correlation with clinicopathologic features and sex steroid receptor status.
    Koshiyama M; Yoshida M; Konishi M; Takemura M; Yura Y; Matsushita K; Hayashi M; Tauchi K
    Int J Cancer; 1997 Jun; 74(3):237-44. PubMed ID: 9221798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium.
    Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ
    In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.